Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer. / Vestbo, J; Langer, S W; Iversen, E T; Viskum, K.

In: Ugeskrift for Laeger, Vol. 157, No. 20, 15.05.1995, p. 2848-50.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Vestbo, J, Langer, SW, Iversen, ET & Viskum, K 1995, 'Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer', Ugeskrift for Laeger, vol. 157, no. 20, pp. 2848-50.

APA

Vestbo, J., Langer, S. W., Iversen, E. T., & Viskum, K. (1995). Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer. Ugeskrift for Laeger, 157(20), 2848-50.

Vancouver

Vestbo J, Langer SW, Iversen ET, Viskum K. Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer. Ugeskrift for Laeger. 1995 May 15;157(20):2848-50.

Author

Vestbo, J ; Langer, S W ; Iversen, E T ; Viskum, K. / Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer. In: Ugeskrift for Laeger. 1995 ; Vol. 157, No. 20. pp. 2848-50.

Bibtex

@article{36efc8fd9681469f8f0bd6ad6a7e464d,
title = "Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer",
abstract = "Frequency and prognostic importance of extrapulmonary manifestations have been examined in 254 patients with intrathoracic sarcoidosis. A follow-up was carried out after a median of 27 years from diagnosis. All patients could be traced. Extrapulmonary manifestations were found in 119 patients (47%), mostly occurring within the first years after diagnosis of intrathoracic sarcoidosis; skin manifestations were most frequently seen. ECG-abnormalities were found in 35 patients (14%); in 17 cases in the form of sinus tachycardia. No excess mortality was found (80 deaths observed versus 66 expected). The causes of death were related to sarcoidosis in 41%. Only tachycardia was associated with an unfavourable prognosis and this association vanished after adjusting for decreased lung function. None of the other extrapulmonary manifestations were associated with an unfavourable vital prognosis. Erythema nodosum was of no prognostic significance concerning survival. In conclusion, extrapulmonary manifestations are frequent in patients with intrathoracic sarcoidosis but do not influence vital prognosis.",
keywords = "Aged, Cardiomyopathies/diagnosis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Sarcoidosis, Pulmonary/diagnosis, Time Factors",
author = "J Vestbo and Langer, {S W} and Iversen, {E T} and K Viskum",
year = "1995",
month = may,
day = "15",
language = "Dansk",
volume = "157",
pages = "2848--50",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "20",

}

RIS

TY - JOUR

T1 - Langtidsprognosen ved pulmonal sarkoidose. 2. Kardial sarkoidose og andre ekstrapulmonale manifestationer

AU - Vestbo, J

AU - Langer, S W

AU - Iversen, E T

AU - Viskum, K

PY - 1995/5/15

Y1 - 1995/5/15

N2 - Frequency and prognostic importance of extrapulmonary manifestations have been examined in 254 patients with intrathoracic sarcoidosis. A follow-up was carried out after a median of 27 years from diagnosis. All patients could be traced. Extrapulmonary manifestations were found in 119 patients (47%), mostly occurring within the first years after diagnosis of intrathoracic sarcoidosis; skin manifestations were most frequently seen. ECG-abnormalities were found in 35 patients (14%); in 17 cases in the form of sinus tachycardia. No excess mortality was found (80 deaths observed versus 66 expected). The causes of death were related to sarcoidosis in 41%. Only tachycardia was associated with an unfavourable prognosis and this association vanished after adjusting for decreased lung function. None of the other extrapulmonary manifestations were associated with an unfavourable vital prognosis. Erythema nodosum was of no prognostic significance concerning survival. In conclusion, extrapulmonary manifestations are frequent in patients with intrathoracic sarcoidosis but do not influence vital prognosis.

AB - Frequency and prognostic importance of extrapulmonary manifestations have been examined in 254 patients with intrathoracic sarcoidosis. A follow-up was carried out after a median of 27 years from diagnosis. All patients could be traced. Extrapulmonary manifestations were found in 119 patients (47%), mostly occurring within the first years after diagnosis of intrathoracic sarcoidosis; skin manifestations were most frequently seen. ECG-abnormalities were found in 35 patients (14%); in 17 cases in the form of sinus tachycardia. No excess mortality was found (80 deaths observed versus 66 expected). The causes of death were related to sarcoidosis in 41%. Only tachycardia was associated with an unfavourable prognosis and this association vanished after adjusting for decreased lung function. None of the other extrapulmonary manifestations were associated with an unfavourable vital prognosis. Erythema nodosum was of no prognostic significance concerning survival. In conclusion, extrapulmonary manifestations are frequent in patients with intrathoracic sarcoidosis but do not influence vital prognosis.

KW - Aged

KW - Cardiomyopathies/diagnosis

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Male

KW - Middle Aged

KW - Prognosis

KW - Sarcoidosis, Pulmonary/diagnosis

KW - Time Factors

M3 - Tidsskriftartikel

C2 - 7785100

VL - 157

SP - 2848

EP - 2850

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 20

ER -

ID: 248231836